NCT05746182View on ClinicalTrials.gov

Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

April 7, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Pancreatic Neuroendocrine Neoplasm
Interventions
DIAGNOSTIC_TEST

Hereditary Cancer Panel

UCSF's Internal Clinical Laboratory Improvement Amendments of 1988 (CLIA)-certified Expanded Hereditary Cancer Panel will be employed which measures a minimum 88 genes

Trial Locations (3)

90095

RECRUITING

University of California, Los Angeles, Los Angeles

92093

RECRUITING

Univeristy of California, San Diego, San Diego

94143

RECRUITING

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

University of California Pancreatic Cancer Consortium (UCPCC)

UNKNOWN

lead

University of California, San Francisco

OTHER